1.5594

1.30% -0.0206

Citius Pharmaceuticals Inc (CTXR)

Overview News Price History Option Chain Financials Why CTXR Down? Discussions Forecast Stock Split

Citius Pharmaceuticals Inc stock is traded at $1.5594, with a volume of 59,300. It is down -1.30% in the last 24 hours and up +13.82% over the past month. Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. The company is currently advancing four proprietary product candidates namely, LYMPHIR for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma. Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections, Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries, Halo-Lido, a topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids, and others.

Previous Close:

$1.58

Open:

$1.57

24h Volume:

59,300

Relative Volume:

0.08

Market Cap:

$26.45M

Revenue:

Net Income/Loss:

$-39.14M

P/E Ratio:

-0.2612

EPS:

-5.97

Net Cash Flow:

$-28.20M

1W Performance:

-3.44%

1M Performance:

+13.82%

6M Performance:

+102.78%

1Y Performance:

-82.62%

1-Day Range:

$1.54

$1.60

1-Week Range:

$1.50

$1.67

52-Week Range:

$0.65

$12.84

Citius Pharmaceuticals Inc Stock (CTXR) Company Profile

Name

Citius Pharmaceuticals Inc

Sector

Healthcare (1137)

Industry

Biotechnology (635)

Phone

(908) 967-6676

Address

11 COMMERCE DRIVE, CRANFORD, NJ

Employee

Twitter

Next Earnings Date

2025-02-07

Latest SEC Filings

CTXR's Discussions on Twitter

Compare CTXR with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
CTXR Citius Pharmaceuticals Inc	1.555	29.19M	0	-39.14M	-28.20M	-5.97
VRTX Vertex Pharmaceuticals Inc	422.98	109.11B	11.39B	3.64B	3.50B	13.99
REGN Regeneron Pharmaceuticals Inc	634.24	68.50B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	434.40	60.25B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	824.45	50.39B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	181.60	40.44B	447.02M	-1.18B	-868.57M	-6.1812

Citius Pharmaceuticals Inc Stock (CTXR) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-30-24	Upgrade	D. Boral Capital	Hold → Buy
Nov-30-21	Initiated	Maxim Group	Buy

Citius Pharmaceuticals Inc Stock (CTXR) Latest News

03:36 AM

Is Citius Pharmaceuticals Inc. (47N0) stock a contrarian opportunityJuly 2025 Catalysts & Capital Efficiency Focused Strategies - newser.com

03:36 AM

03:07 AM

Is Citius Pharmaceuticals Inc. stock attractive for passive investors - newser.com

03:07 AM

02:46 AM

How Citius Pharmaceuticals Inc. (47N0) stock reacts to new regulationsQuarterly Profit Report & AI Based Buy/Sell Signal Reports - newser.com

02:46 AM

01:39 AM

Full technical analysis of Citius Pharmaceuticals Inc. stockWeekly Investment Report & Weekly Hot Stock Watchlists - newser.com

01:39 AM

01:15 AM

Applying Elliott Wave Theory to Citius Pharmaceuticals Inc.Quarterly Earnings Summary & Smart Swing Trading Techniques - newser.com

01:15 AM

Nov 02, 2025

Why Citius Pharmaceuticals Inc. stock could outperform in 20252025 Market WrapUp & Free Technical Confirmation Trade Alerts - newser.com

Nov 02, 2025

Should you wait for a breakout in Citius Pharmaceuticals Inc.Market Risk Report & Safe Entry Momentum Stock Tips - newser.com

Nov 02, 2025

Citius Pharmaceuticals Inc. stock chart pattern explainedWeekly Investment Report & Fast Entry Momentum Alerts - newser.com

Nov 02, 2025

Nov 01, 2025

Can Citius Pharmaceuticals Inc. stock sustain market leadershipStop Loss & Fast Momentum Entry Tips - newser.com

Nov 01, 2025

Is Citius Pharmaceuticals Inc. (47N0) stock in buy zone after pullbackIPO Watch & Safe Capital Preservation Plans - newser.com

Nov 01, 2025

Is Citius Pharmaceuticals Inc. stock a buy before product launches2025 Market Sentiment & Free Safe Entry Trade Signal Reports - newser.com

Nov 01, 2025

Oct 31, 2025

What MACD and RSI say about Citius Pharmaceuticals Inc.Weekly Trend Report & Accurate Intraday Trading Signals - newser.com

Oct 31, 2025

Can a trend reversal in Citius Pharmaceuticals Inc. lead to recovery2025 Trading Volume Trends & Accurate Entry/Exit Alerts - newser.com

Oct 31, 2025

Is Citius Pharmaceuticals Inc. (47N0) stock undervalued at current priceRecession Risk & High Return Stock Watch Alerts - newser.com

Oct 31, 2025

Has Citius Pharmaceuticals Inc. found a price floor2025 Major Catalysts & Fast Exit and Entry Strategy Plans - newser.com

Oct 31, 2025

Heatmap analysis for Citius Pharmaceuticals Inc. and competitors2025 AllTime Highs & Low Risk Growth Stock Ideas - newser.com

Oct 31, 2025

What Wall Street predicts for Citius Pharmaceuticals Inc. stock priceJuly 2025 Patterns & Free Community Consensus Stock Picks - newser.com

Oct 31, 2025

Will Citius Pharmaceuticals Inc. (47N0) stock deliver compounding returnsJuly 2025 Summary & Expert Approved Trade Ideas - newser.com

Oct 31, 2025

Oct 30, 2025

Long term hold vs stop loss in Citius Pharmaceuticals Inc.Forecast Cut & Fast Exit/Entry Strategy Plans - newser.com

Oct 30, 2025